Sophie V. Vandebroek sold $920k of IDXX
director at IDEXX LABORATORIES INC /DE. 1,464 shares at an average of $628.62, traded Feb 17, 2026, filed Feb 19, 2026.
Score components
- +15RoleDirector
- +24Trade size$920k at market
- +20Share of holdings soldSold 69% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000874716-26-000032, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 17, 2026 | MOption exercise Common Stock | +945 | $333.90 | $316k | 2,112 | Feb 19, 2026 |
| Feb 17, 2026 | SOpen-market sale Common Stock | -945 | $628.65 | $594k | 1,167 | Feb 19, 2026 |
| Feb 17, 2026 | SOpen-market sale Common Stock | -519 | $628.56 | $326k | 648 | Feb 19, 2026 |
| Feb 17, 2026 | MOption exercise Non-Qualified Stock Option (right-to-buy)derivative | -945 | - | - | 0 | Feb 19, 2026 |
Related signals
Other insiders at IDEXX LABORATORIES INC /DE and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | IDXXsell IDEXX LABORATORIES INC /DE | Lawrence D Kingsley director | $1.2M 2,203 shares | -19% | |
| 55Moderate | IDEXX LABORATORIES INC /DE | Nimrata Hunt Executive Vice President | $1.1M 1,758 shares | -9% | |
| 55Moderate | IDEXX LABORATORIES INC /DE | Jonathan Jay Mazelsky President and CEO | $15M 23,326 shares | -22% | |
| 60Notable | IDEXX LABORATORIES INC /DE | Nimrata Hunt Executive Vice President | $1.8M 2,693 shares | -12% | |
| 50Moderate | IDEXX LABORATORIES INC /DE | Michael G Erickson Executive Vice President | $3.4M 5,371 shares | -30% | |
| 60Notable | IDEXX LABORATORIES INC /DE | George Fennell Executive Vice President | $7.3M 11,345 shares | -54% | |
| 35Weak | IDXXsell IDEXX LABORATORIES INC /DE | Nimrata Hunt Executive Vice President | $6.6M 9,425 shares | -31% | |
| 60Notable | IDEXX LABORATORIES INC /DE | M Anne Szostak director | $1.4M 2,187 shares | -89% | |
| 43Moderate | IDEXX LABORATORIES INC /DE | Michael G Erickson Executive Vice President | $264k 406 shares | -3% | |
| 37Weak | IDEXX LABORATORIES INC /DE | Nimrata Hunt Executive Vice President | $788k 1,200 shares | -7% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.